Authors: Albert A. Davis
Published: 2020-05-20
DOI: 10.1126/scitranslmed.abb7100
Source: Full article
Analysis of peripheral blood mononuclear cells demonstrated that α-synuclein–specific T cells are active in preclinical and early Parkinson’s disease.